# Ladenburg Thalmann

> Ladenburg Thalmann & Co. Inc. is a New York investment bank founded in 1876 and owned by Osaic Holdings. It helps middle-market companies raise equity and debt, advises on corporate transactions, and provides sector-focused equity research, institutional sales and trading, and private client services. Its research website lists approximately 150 covered companies with a median market capitalization of $350 million.

- **Founded:** 1876
- **Headquarters:** New York, United States
- **Founders:** Adolph Ladenburg (Co-founder), Ernst Thalmann (Co-founder)
- **Products:** Equity and debt capital raising, Corporate finance and M&A advisory, Equity research, Institutional sales and trading, Corporate access
- **Notable:** Founded in 1876 and an NYSE member since 1879., Reached its 150th anniversary in 2026; the company website shows a July 9, 2026 NYSE closing-bell celebration., Exclusive placement agent on enVVeno Medical’s approximately $28 million October 2023 financing.

## Products & services

- **Equity and debt capital raising** — IPOs, follow-on offerings, registered directs, at-the-market programs, PIPEs, private placements, fixed-income offerings and royalty/revenue-interest financing.
- **Corporate finance and M&A advisory** — Mergers and acquisitions, buyouts, going-private transactions, divestitures, restructuring, valuations, fairness and solvency opinions.
- **Equity research** — Sector-focused research; the website lists 12 analysts, approximately 150 covered companies and a $350 million median covered-company market capitalization, observed October 2026.
- **Institutional sales and trading** — Execution in debt, equity and derivative products, including block trades, Nasdaq market-making, options, ETFs and algorithmic capabilities.
- **Corporate access** — Non-deal roadshows, forums, one-on-one meetings, conferences, calls and site visits connecting companies with institutional investors.
- **Private client services** — Retirement, managed-account, cash-management, estate and education planning; investment advisory services are offered through the separate LTAM entity.

## Achievements

- Founded in 1876 and an NYSE member since 1879.
- Reached its 150th anniversary in 2026; the company website shows a July 9, 2026 NYSE closing-bell celebration.
- Exclusive placement agent on enVVeno Medical’s approximately $28 million October 2023 financing.
- Expanded REIT research with Floris van Dijkum in July 2025 and biotechnology research with two senior analysts in June 2026.

## Latest updates

- **2026-09** — Company transaction gallery lists a $15 million Intelligent Bio Solutions private placement with Ladenburg as exclusive placement agent; gallery amount is not independently treated as net proceeds.
- **2026-07** — Celebrated 150 years at the NYSE closing bell on July 9.
- **2026-06** — Added Rick Bienkowski, Ph.D., and Caroline Palomeque as managing directors in biotechnology equity research.
- **2026-04** — Moved Aydin Huseynov from equity research into biotechnology investment banking.
- **2025-12** — Announced Meredith Sondler-Bazar’s addition to healthcare investment banking; page metadata says December 9 while release text says December 12.

## Links

- Website: https://www.ladenburg.com
- LinkedIn: https://www.linkedin.com/company/ladenburg-thalmann/
- Twitter/X: https://x.com/LadenburgLTS
- Facebook: https://www.facebook.com/ladenburglts

---

Profile page: https://yespress.io/ladenburg-thalmann
Published by YesPress — https://yespress.io
Last updated: 2026-10-22